Cargando…
Imatinib Mesylate Effectiveness in Chronic Myeloid Leukemia with Additional Cytogenetic Abnormalities at Diagnosis among Black Africans
Imatinib mesylate provides good results in the treatment of CML in general. But what about the results of this treatment in CML associated with additional cytogenetic abnormalities at diagnosis among black Africans? For this, we retrospectively studied 27 cases of CML associated with additional cyto...
Autores principales: | Aïssata, Tolo Diebkilé, Sawadogo, Duni, Nanho, Clotaire, Kouakou, Boidy, Meité, N'dogomo, Emeuraude, N'Dhatz, Roméo, Ayémou, Yassongui Mamadou, Sekongo, Kouéhion, Paul, Mozart, Konan, Koffi, Gustave, Sanogo, Ibrahima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681263/ https://www.ncbi.nlm.nih.gov/pubmed/23802015 http://dx.doi.org/10.1155/2013/901589 |
Ejemplares similares
-
Characteristics and Results of the Treatment of Multiple Myeloma in the Subject under the Age of 65 at the University Hospital of Yopougon in Abidjan, Côte d'Ivoire
por: Tolo, Diebkilé Aïssata, et al.
Publicado: (2013) -
Characteristics and Results of the Management of Diffuse Large B-Cell Lymphomas: The Experience of Côte d'Ivoire
por: Tolo Diebkilé, Aïssata, et al.
Publicado: (2012) -
The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire
por: Koffi, K. G., et al.
Publicado: (2010) -
Nonreplacement therapy for hemophilia in low-income countries: experience from a prospective study in Ivory Coast
por: Lambert, Catherine, et al.
Publicado: (2022) -
Interest in Determining the CD34+ CD38− Phenotype in the Diagnosis and Prognosis of Acute Leukemia in Abidjan – Côte d’Ivoire
por: Sawadogo, Duni, et al.
Publicado: (2013)